Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Eiken Chemical Co., Ltd. ( (JP:4549) ).
Eiken Chemical has received a shareholder proposal from activist investor Nippon Active Value Fund to appoint two new directors at its June 23 annual general meeting. After reviewing the proposal, the board has formally resolved to oppose the election of these candidates and has disclosed its position to shareholders.
The board argues that the proposed directors, linked to Dalton Investments and Rising Sun Management, do not meet the company’s independence standards due to their ties to major shareholders holding significant stakes in Eiken. Management warns that appointing these nominees could weaken independent oversight of management and misalign the board’s governance structure with its existing independence framework, signaling resistance to activist influence over corporate strategy.
More about Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. is a Japanese diagnostics and chemical company listed on the TSE Prime with securities code 4549. The company develops and supplies clinical testing reagents, diagnostic systems, and related products, serving healthcare institutions and laboratories in Japan and overseas.
Average Trading Volume: 176,271
Technical Sentiment Signal: Buy
Current Market Cap: Yen100.6B
For a thorough assessment of 4549 stock, go to TipRanks’ Stock Analysis page.